CClinicalTrials.gg
CompletedNCT05037708Updated Apr 6, 2023

Effects of Physiotherapy in the Treatment of Lymphedema After Breast Cancer

An interventional study of Manual lymphatic drainage and Manual lymphatic drainage in Lymphedema of Upper Limb, sponsored by University of Vigo. Completed at 1 site in Spain. Open to female participants. Per ClinicalTrials.gov, last updated 2023-04-06.

Sponsored by University of Vigo · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
28
Allocation
Randomized
Sex
Female
01

Study summary

Lymphedema related to breast cancer is one of the main complications after breast cancer treatment. Manual lymphatic drainage appears as a technique which could be applied in the treatment of lymphedema along with other techniques. The aim of this study is to analyze the effects of a physiotherapy program based on manual lymphatic drainage on the treatment of lymphedema after breast cancer, during the stabilization or maintenance phase of complex decongestant therapy. Therefore, a randomized, blinded, crossover clinical trial is suggested to assess the effect of an intensive physiotherapy intervention on the treatment of lymphedema in its maintenance phase, in comparison with a control group without physiotherapy treatment. The cytometry, displaced water volume, thickness of the lymphedema with ultrasound, dynamometry and sensation of heaviness, pain and tension of the upper limb will be evaluated.

Read the detailed description

Complex decongestant therapy is a set of techniques which seek the treatment of lymphedema in a conservative way as described in the recent international consensus of the International Lymphology Society, published in 2020. Complex decongestant therapy in a first phase aims to reduce cutaneous edema and in a second phase it aims to preserve and optimize the results obtained.

The first phase consists of skin care, manual lymphatic drainage, muscle pumping exercises, and compression techniques, typically applied with multilayer bandages. The second phase consists of compression with low elasticity, skin care exercises, and repeated manual lymphatic drainage as needed.

The frequency and intensity of components of complex decongestant therapy in phase I and II should depend on the clinical findings of edema and the stage of lymphedema and could be adapted to clinical changes. Note that phase II or stabilization represents long-term therapy over many years and in the case of deterioration of edema, phase I of complex decongestant therapy may need to be repeated.

In recent years, there is debate about the efficacy of manual lymphatic drainage. Sometimes it is not prescribed, being replaced by the recommendation of a self-massage. Furthermore, complex decongestant therapy was suggested to be time consuming, expensive and difficult to tolerate, and does not improve lymphatic function.

In contrast, researchers such as Müller et al., in 2018, state that it is a well-tolerated and safe treatment technique, demonstrating benefits in reducing edema. Other research has also shown that manual lymphatic drainage is effective both on a preventive level and as a postoperative rehabilitation treatment, having optimal results when combined with the other elements of complex decongestant therapy.

A recent systematic review published in 2020 highlights the need of more experimental studies on the effectiveness of manual lymphatic drainage on lymphedema. Thus, the

purpose of this study is to analyze the effects of a physiotherapy program based on manual lymphatic drainage in the treatment of lymphedema after breast cancer, during the stabilization or maintenance phase of complex decongestant therapy. Therefore, a double-blind crossover clinical trial is proposed.

02

Conditions studied

  • Lymphedema of Upper Limb

Browse trials for

Keywords

  • Lymphedema of Upper Limb
  • Breast Neoplasms
  • Physical Therapy Modalities
03

In context

Lymphedema

560 studies on the registry are indexed under Lymphedema; 135 are open to participants now.

This study's enrollment of 28 is below the median of 50 across 403 interventional studies indexed under Lymphedema.

Browse Lymphedema studies →

Lead sponsor

University of Vigo is the lead sponsor of 53 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Women included in the lymphedema treatment maintenance program through the Galician Lymphedema Association
  • Women with secondary unilateral lymphedema after breast cancer

Exclusion criteria

Exclusion Criteria:

  • Women undergoing chemotherapy or radiotherapy treatment.
  • Severe systemic or neurological disease
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
28 participants (actual)

Study arms

  • Experimental
    Group 1

    Group 1 receives treatment A for 4 weeks. Afterwards, a period of washing or bleaching should be allowed in order to be sure that the effects of the intervention have disappeared. This period will last 2 months during which the usual treatment for LGA patients will be carried out, which consists of 2 monthly physiotherapy sessions, in this way it is intended that the subjects are in the initial state (as before the start of the first intervention). After this washout period, treatment B was applied to group 1.

    Procedure: Manual lymphatic drainage

  • Active comparator
    Group 2

    Group 2 receives treatment B for 4 weeks. Afterwards, a period of washing or bleaching should be allowed in order to be sure that the effects of the intervention have disappeared. This period will last 2 months during which the usual treatment for LGA patients will be carried out, which consists of 2 monthly physiotherapy sessions, in this way it is intended that the subjects are in the initial state (as before the start of the first intervention). After this washout period, treatment A was applied to group 2 .

    Procedure: Manual lymphatic drainage

Interventions

  • ProcedureManual lymphatic drainage

    Subjects are randomly assigned to group 1. Group 1 receives treatment A\* for 4 weeks. Afterwards, a period of washing or bleaching should be allowed in order to be sure that the effects of the intervention have disappeared. This period will last 2 months during which the usual treatment for LGA patients will be carried out, which consists of 2 monthly physiotherapy sessions, in this way it is intended that the subjects are in the initial state (as before the start of the first intervention). After this washout period, treatment B\*\* was applied to group 1 for 4 weeks. \*Treatment A consists of manual lymphatic drainage. \*\*Treatment B consists of no treatment

  • ProcedureManual lymphatic drainage

    Subjects are randomly assigned to group 2. Group 2 receives treatment B\*\* for 4 weeks. Afterwards, a period of washing or bleaching should be allowed in order to be sure that the effects of the intervention have disappeared. This period will last 2 months during which the usual treatment for LGA patients will be carried out, which consists of 2 monthly physiotherapy sessions, in this way it is intended that the subjects are in the initial state (as before the start of the first intervention). After this washout period, treatment A\* was applied to group 2 for 4 weeks. \*Treatment A consists of manual lymphatic drainage. \*\*Treatment B consists of no treatment

06

What researchers measure

Primary outcomes

  1. circometry

    measurement of upper limb perimeters

    Time frame: 1 day

  2. circometry

    measurement of upper limb perimeters

    Time frame: 1 month

  3. circometry

    measurement of upper limb perimeters

    Time frame: 3 month

  4. circometry

    measurement of upper limb perimeters

    Time frame: 4 month

  5. Volumetry by water displacement

    weight of water extravasated when introducing the upper limb into a container with water

    Time frame: 1 day

  6. Volumetry by water displacement

    weight of water extravasated when introducing the upper limb into a container with water

    Time frame: 1 month

  7. Volumetry by water displacement

    weight of water extravasated when introducing the upper limb into a container with water

    Time frame: 3 month

  8. Volumetry by water displacement

    weight of water extravasated when introducing the upper limb into a container with water

    Time frame: 4 month

  9. Measurement of edema thickness by ultrasound

    measurement of subcutaneous tissue thickness

    Time frame: 1 day

  10. Measurement of edema thickness by ultrasound

    measurement of subcutaneous tissue thickness

    Time frame: 1 month

  11. Measurement of edema thickness by ultrasound

    measurement of subcutaneous tissue thickness

    Time frame: 3 month

  12. Measurement of edema thickness by ultrasound

    measurement of subcutaneous tissue thickness

    Time frame: 4 month

Secondary outcomes

  1. Assessment of the sensation of heaviness

    Visual analogic scale

    Time frame: 1 day

  2. Assessment of the sensation of heaviness

    Visual analogic scale

    Time frame: 1 month

  3. Assessment of the sensation of heaviness

    Visual analogic scale

    Time frame: 3 month

  4. Assessment of the sensation of heaviness

    Visual analogic scale

    Time frame: 4 month

  5. Assessment of the sensation of pain

    Visual analogic scale

    Time frame: 1 day

  6. Assessment of the sensation of pain

    Visual analogic scale

    Time frame: 1 month

  7. Assessment of the sensation of pain

    Visual analogic scale

    Time frame: 3 month

  8. Assessment of the sensation of pain

    Visual analogic scale

    Time frame: 4 month

  9. Assessment of the sensation of tension in the upper limb

    Visual analogic scale

    Time frame: 1 day

  10. Assessment of the sensation of tension in the upper limb

    Visual analogic scale

    Time frame: 1 month

  11. Assessment of the sensation of tension in the upper limb

    Visual analogic scale

    Time frame: 3 month

  12. Assessment of the sensation of tension in the upper limb

    Visual analogic scale

    Time frame: 4 month

  13. dynamometry

    Assessment of muscle grip strength by dynamometry

    Time frame: 1 day

  14. dynamometry

    Assessment of muscle grip strength by dynamometry

    Time frame: 1 month

  15. dynamometry

    Assessment of muscle grip strength by dynamometry

    Time frame: 3 month

  16. dynamometry

    Assessment of muscle grip strength by dynamometry

    Time frame: 4 month

07

Study locations

1 site
  • Faculty of Physiotherapy
    Pontevedra, 36005, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05037708
Lead sponsor
University of Vigo
Collaborators
Asociación Gallega de Linfedema
Responsible party
Eva María Lantarón Caeiro (Principal Investigator, University of Vigo) — Principal investigator
First posted
Sep 8, 2021
Start date
Mar 1, 2022
Primary completion
Jul 1, 2022
Completion
Oct 27, 2022
Last update
Apr 6, 2023

Study contacts

Eva M Lantarón_Caeiro, Dra
principal investigator · Physiotherapy Group (FS1) - Faculty of Physiotherapy -University of Vigo

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion